Johns Hopkins engineers report millirobots roughly the width of a pencil tip and about as long as a grain of rice. Observed facts: the needle module is designed to latch onto heart tissue while a separate drug module docks and releases antibiotics; both are guided wirelessly by an external electromagnetic coil system. The team tested the robots in phantom heart models and real porcine heart tissue, where they moved against simulated blood flow.
Mechanism: The two-part arrangement lets a docking point remain in place while the drug module can be replaced for repeat dosing. External magnetic guidance avoids carrying batteries and motors in the robots. This is a different engineering proposition from simply miniaturizing a single drug-carrying robot: localization and payload delivery are separated into cooperating components.
Why now: Existing endocarditis treatment can require four to six weeks of intravenous antibiotics, and the source says drugs may be too diluted by the time they reach the heart. Implications: If later validated, a repeatable local-delivery procedure could reduce systemic exposure and make hard-to-reach targets more accessible; the university article's shorter-treatment scenario remains a possibility, not a measured patient outcome.
Evidence boundary: The reported tests are in models and porcine tissue, not people; the team's next stated step is testing in more realistic phantom hearts with muscle contraction. Watch condition: Whether the robots can reliably reach, dock, and release a controlled dose in a moving-heart model is the next meaningful validation gate.